Fever of Unknown Origin in HIV/AIDS Patients

Infectious Disease Clinics of North America

Volumn 21, Issue 4, 2007, Pages 1013-1032

  Hot, Arnaud ^a   Schmulewitz, Laura ^a   Viard, Jean Paul ^a   Lortholary, Olivier ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; AMPRENAVIR; ANTIRETROVIRUS AGENT; BETA LACTAM ANTIBIOTIC; COTRIMOXAZOLE; DAPSONE; ENFUVIRTIDE; FLUORODEOXYGLUCOSE F 18; GALLIUM 67; ISONIAZID; LACTATE DEHYDROGENASE; NEVIRAPINE; PYRAZINAMIDE; RIFAMPICIN; SULFONAMIDE; ZIDOVUDINE;

AIDS PATIENT; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ANTIBIOTIC PROPHYLAXIS; ASPERGILLOSIS; BACTERIUM CULTURE; BLOOD CULTURE; BONE MARROW BIOPSY; CD4 LYMPHOCYTE COUNT; CLINICAL FEATURE; COCCIDIOIDOMYCOSIS; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; DISEASE DURATION; DRUG ERUPTION; DRUG FEVER; DRUG HYPERSENSITIVITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPLASMA CAPSULATUM; HISTOPLASMOSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; INJECTION SITE REACTION; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER BIOPSY; LUNG ASPERGILLOSIS; LUNG INFECTION; LUNG SARCOIDOSIS; MYCOBACTERIUM TUBERCULOSIS; OPPORTUNISTIC INFECTION; PATIENT ASSESSMENT; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTIS PNEUMONIA; POLYMERASE CHAIN REACTION; POSITRON EMISSION TOMOGRAPHY; PYREXIA IDIOPATHICA; REVIEW; SKIN BIOPSY; TOXOPLASMOSIS; TRANSTHORACIC ECHOCARDIOGRAPHY; VIRUS CULTURE; VISCERAL LEISHMANIASIS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AIDS-RELATED OPPORTUNISTIC INFECTIONS; BACTERIAL INFECTIONS; FEVER OF UNKNOWN ORIGIN; HUMANS; MYCOSES; PARASITIC DISEASES; VIRUS DISEASES;

EID: 36448972260     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.idc.2007.08.003     Document Type: Review

References (95)

1. Arnow P.M., and Flaherty J.P. Fever of unknown origin. Lancet 350 9077 (1997) 575-580
2. Lortholary O., Guilletin L., Blétry O., et al. Fever of unknown origin: a retrospective multicentric study of 103 cases, 1980-1988. Eur J Intern Med 1 3 (1992) 109-120
3. Vanderschueren S., Knockaert D., Adriaenssens T., et al. From prolonged febrile illness to fever of unknown origin: the challenge continues. Arch Intern Med 163 9 (2003) 1033-1041
4. Mayo J., Collazos J., and Martinez E. Fever of unknown origin in the HIV-infected patient: new scenario for an old problem. Scand J Infect Dis 29 4 (1997) 327-336
5. Lozano F., Torre-Cisneros J., Santos J., et al. Impact of highly active antiretroviral therapy on fever of unknown origin in HIV-infected patients. Eur J Clin Microbiol Infect Dis 21 2 (2002) 137-139
6. Durack D.T., and Street A.C. Fever of unknown origin: reexamined and redefined. Curr Clin Top Infect Dis 11 (1991) 35-51
7. Bissuel F., Leport C., Perronne C., et al. Fever of unknown origin in HIV-infected patients: a critical analysis of a retrospective series of 57 cases. J Intern Med 236 5 (1994) 529-535
8. Lozano F., Torre-Cisneros J., Bascunana A., et al. Prospective evaluation of fever of unknown origin in patients infected with the human immunodeficiency virus. Grupo Andaluz para el Estudio de las Enfermedades Infecciosas. Eur J Clin Microbiol Infect Dis 15 9 (1996) 705-711
9. Miller R.F., Hingorami A.D., and Foley N.M. Pyrexia of undetermined origin in patients with human immunodeficiency virus infection and AIDS. Int J STD AIDS 7 3 (1996) 170-175
10. Miralles P., Moreno S., Perez-Tascon M., et al. Fever of uncertain origin in patients infected with the human immunodeficiency virus. Clin Infect Dis 20 4 (1995) 872-875
11. Armstrong W.S., Katz J.T., and Kazanjian P.H. Human immunodeficiency virus-associated fever of unknown origin: a study of 70 patients in the United States and review. Clin Infect Dis 28 2 (1999) 341-345
12. Palella Jr. F.J., Delaney K.M., Moorman A.C., et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 338 13 (1998) 853-860
13. Bernabeu-Wittel M., Villanueva J.L., Pachon J., et al. Etiology, clinical features and outcome of splenic microabscesses in HIV-infected patients with prolonged fever. Eur J Clin Microbiol Infect Dis 18 5 (1999) 324-329
14. Genne D., Chave J.P., and Glauser M.P. [Fever of unknown origin in a cohort of HIV-positive patients]. Schweiz Med Wochenschr 122 47 (1992) 1797-1802 [in French]
15. Carbonell Biot C.E.M.J., Pasquau Liano F., Badia Ferrando P., et al. Fiebre de origen desconocido en pacientes infectados por el virus de la immunodeficiencia humana. Rev Clin Esp 196 1 (1996) 4-8
16. Knobel H., Supevia A., Salvado M., et al. [Fever of unknown origin in patients with human immunodeficiency virus infection: study of 100 cases]. Rev Clin Esp 196 6 (1996) 349-353 [in Spanish]
17. Riera M., Altes J., Homar F., et al. [Fever of unknown origin in patients with HIV infection]. Enferm Infecc Microbiol Clin 14 10 (1996) 581-585 [in Spanish]
18. Larson E.B., Featherstone H.J., and Petersdorf R.G. Fever of undetermined origin: diagnosis and follow-up of 105 cases, 1970-1980. Medicine (Baltimore) 61 5 (1982) 269-292
19. Mocroft A., Ledergerber B., Katlama C., et al. Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet 362 9377 (2003) 22-29
20. Meynard J.L., Guiguet M., Fonquernie L., et al. Impact of highly active antiretroviral therapy on the occurrence of bacteraemia in HIV-infected patients and their epidemiologic characteristics. HIV Med 4 2 (2003) 127-132
21. Carbonell Biot C., Ena Munoz J., Pasquau Liano F., et al. [Fever of unknown origin in patients infected with the human immunodeficiency virus]. Rev Clin Esp 196 1 (1996) 4-8 [in Spanish]
22. Dye C., Scheele S., Dolin P., et al. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 282 7 (1999) 677-686
23. Havlir D.V., and Barnes P.F. Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med 340 5 (1999) 367-373
24. Mayo J., Collazos J., and Martinez E. Fever of unknown origin in the setting of HIV infection: guidelines for a rational approach. AIDS Patient Care STDS 12 5 (1998) 373-378
25. Getahun H., Harrington M., O'Brien R., et al. Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes. Lancet 369 9578 (2007) 2042-2049
26. Navarro V., Guix J., Bernacer B., et al. [Tuberculosis and human immunodeficiency virus infection: a prospective study of 215 patients]. Rev Clin Esp 192 7 (1993) 315-320 [in Spanish]
27. Barnes P.F., Lakey D.L., and Burman W.J. Tuberculosis in patients with HIV infection. Infect Dis Clin North Am 16 1 (2002) 107-126
28. Dheda K., Lampe F.C., Johnson M.A., et al. Outcome of HIV-associated tuberculosis in the era of highly active antiretroviral therapy. J Infect Dis 190 9 (2004) 1670-1676
29. Karstaedt A.S., Pantanowitz L., Omar T., et al. The utility of bone-marrow examination in HIV-infected adults in South Africa. QJM 94 2 (2001) 101-105
30. Jani K., and Mehta N.J. Pneumocystis carinii pneumonia presenting as a fever of unknown origin in a patient without AIDS. Heart Lung 31 1 (2002) 50-52
31. Cunha B.A. Fever or unknown origin in HIV/AIDS patients. Drugs Today (Barc) 35 6 (1999) 429-434
32. Morris A., Kingsley L.A., Groner G., et al. Prevalence and clinical predictors of Pneumocystis colonization among HIV-infected men. AIDS 18 5 (2004) 793-798
33. Gerard L., Leport C., Flandre P., et al. Cytomegalovirus (CMV) viremia and the CD4+ lymphocyte count as predictors of CMV disease in patients infected with human immunodeficiency virus. Clin Infect Dis 24 5 (1997) 836-840
34. Sullivan M., Feinberg J., and Bartlett J.G. Fever in patients with HIV infection. Infect Dis Clin North Am 10 1 (1996) 149-165
35. Jabs D.A., Van Natta M.L., Kempen J.H., et al. Characteristics of patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Am J Ophthalmol 133 1 (2002) 48-61
36. Bowen E.F., Sabin C.A., Wilson P., et al. Cytomegalovirus (CMV) viraemia detected by polymerase chain reaction identifies a group of HIV-positive patients at high risk of CMV disease. AIDS 11 7 (1997) 889-893
37. Nokta M.A., Holland F., De Gruttola V., et al. Cytomegalovirus (CMV) polymerase chain reaction profiles in individuals with advanced human immunodeficiency virus infection: relationship to CMV disease. J Infect Dis 185 12 (2002) 1717-1722
38. Deayton J.R., Prof Sabin C.A., Johnson M.A., et al. Importance of cytomegalovirus viraemia in risk of disease progression and death in HIV-infected patients receiving highly active antiretroviral therapy. Lancet 363 9427 (2004) 2116-2121
39. Smith I.L., Macdonald J.C., Freeman W.R., et al. Cytomegalovirus (CMV) retinitis activity is accurately reflected by the presence and level of CMV DNA in aqueous humor and vitreous. J Infect Dis 179 5 (1999) 1249-1253
40. Antinori S., Magni C., Nebuloni M., et al. Histoplasmosis among human immunodeficiency virus-infected people in Europe: report of 4 cases and review of the literature. Medicine (Baltimore) 85 1 (2006) 22-36
41. Couppie P., Sobesky M., Aznar C., et al. Histoplasmosis and acquired immunodeficiency syndrome: a study of prognostic factors. Clin Infect Dis 38 1 (2004) 134-138
42. Wheat L.J., Connolly-Stringfield P.A., Baker R.L., et al. Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature. Medicine (Baltimore) 69 6 (1990) 361-374
43. Corcoran G.R., Al-Abdely H., Flanders C.D., et al. Markedly elevated serum lactate dehydrogenase levels are a clue to the diagnosis of disseminated histoplasmosis in patients with AIDS. Clin Infect Dis 24 5 (1997) 942-944
44. Akpek G., Lee S.M., Gagnon D.R., et al. Bone marrow aspiration, biopsy, and culture in the evaluation of HIV-infected patients for invasive mycobacteria and histoplasma infections. Am J Hematol 67 2 (2001) 100-106
45. Kauffman C.A. Histoplasmosis: a clinical and laboratory update. Clin Microbiol Rev 20 1 (2007) 115-132
46. Woods C.W., McRill C., Plikaytis B.D., et al. Coccidioidomycosis in human immunodeficiency virus-infected persons in Arizona, 1994-1997: incidence, risk factors, and prevention. J Infect Dis 181 4 (2000) 1428-1434
47. Maubon D., Simon S., and Aznar C. Histoplasmosis diagnosis using a polymerase chain reaction method: application on human samples in French Guiana, South America. Diagn Microbiol Infect Dis 58 (2007) 441-444
48. Arguinchona H.L., Ampel N.M., Dols C.L., et al. Persistent coccidioidal seropositivity without clinical evidence of active coccidioidomycosis in patients infected with human immunodeficiency virus. Clin Infect Dis 20 5 (1995) 1281-1285
49. Fish D.G., Ampel N.M., Galgiani J.N., et al. Coccidioidomycosis during human immunodeficiency virus infection: a review of 77 patients. Medicine (Baltimore) 69 6 (1990) 384-391
50. Rosenthal E., Marty P., Poizot-Martin I., et al. Visceral leishmaniasis and HIV-1 co-infection in southern France. Trans R Soc Trop Med Hyg 89 2 (1995) 159-162
51. Singh N., and Perfect J.R. Immune reconstitution syndrome associated with opportunistic mycoses. Lancet Infect Dis 7 6 (2007) 395-401
52. Medrano F.J., Jimenez-Mejias E., Calderon E., et al. An easy and quick method for the diagnosis of visceral leishmaniasis in HIV-1-infected individuals. AIDS 7 10 (1993) 1399
53. Maurya R., Singh R.K., Kumar B., et al. Evaluation of PCR for diagnosis of Indian kala-azar and assessment of cure. J Clin Microbiol 43 7 (2005) 3038-3041
54. Antinori S., Calattini S., Longhi E., et al. Clinical use of polymerase chain reaction performed on peripheral blood and bone marrow samples for the diagnosis and monitoring of visceral leishmaniasis in HIV-infected and HIV-uninfected patients: a single-center, 8-year experience in Italy and review of the literature. Clin Infect Dis 44 12 (2007) 1602-1610
55. Murata M., Furusyo N., Otaguro S., et al. HIV infection with concomitant cerebral toxoplasmosis and disseminated histoplasmosis in a 45-year-old man. J Infect Chemother 13 1 (2007) 51-55
56. Dromer F., Mathoulin-Pelissier S., Launay O., et al. Determinants of disease presentation and outcome during cryptococcosis: The CryptoA/D Study. PLoS Med 4 2 (2007) e21
57. Lortholary O., Poizat G., Zeller V., et al. Long-term outcome of AIDS-associated cryptococcosis in the era of combination antiretroviral therapy. AIDS 20 17 (2006) 2183-2191
58. Lortholary O., Meyohas M.C., Dupont B., et al. Invasive aspergillosis in patients with acquired immunodeficiency syndrome: report of 33 cases. French Cooperative Study Group on Aspergillosis in AIDS. Am J Med 95 2 (1993) 177-187
59. Duong T.A. Infection due to Penicillium marneffei, an emerging pathogen: review of 155 reported cases. Clin Infect Dis 23 1 (1996) 125-130
60. Supparatpinyo K., Khamwan C., Baosoung V., et al. Disseminated Penicillium marneffei infection in southeast Asia. Lancet 344 8915 (1994) 110-113
61. Wong S.S., Wong K.H., Hui W.T., et al. Differences in clinical and laboratory diagnostic characteristics of penicilliosis marneffei in human immunodeficiency virus (HIV)- and non-HIV-infected patients. J Clin Microbiol 39 12 (2001) 4535-4540
62. Zylberberg H., Robert F., Le Gal F.A., et al. Prolonged isolated fever due to attenuated extracerebral toxoplasmosis in patients infected with human immunodeficiency virus who are receiving trimethoprim-sulfamethoxazole as prophylaxis. Clin Infect Dis 21 3 (1995) 680-681
63. Koehler J.E., Sanchez M.A., Tye S., et al. Prevalence of Bartonella infection among human immunodeficiency virus-infected patients with fever. Clin Infect Dis 37 4 (2003) 559-566
64. Tea A., Alexiou-Daniel S., Arvanitidou M., et al. Occurrence of Bartonella henselae and Bartonella quintana in a healthy Greek population. Am J Trop Med Hyg 68 5 (2003) 554-556
65. Falagas M.E., and Klempner M.S. Babesiosis in patients with AIDS: a chronic infection presenting as fever of unknown origin. Clin Infect Dis 22 5 (1996) 809-812
66. Sepkowitz K.A., Telzak E.E., Carrow M., et al. Fever among outpatients with advanced human immunodeficiency virus infection. Arch Intern Med 153 16 (1993) 1909-1912
67. Clifford G.M., Polesel J., Rickenbach M., et al. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst 97 6 (2005) 425-432
68. Lim S.T., and Levine A.M. Recent advances in acquired immunodeficiency syndrome (AIDS)-related lymphoma. CA Cancer J Clin 55 4 (2005) 229-241 260-1, 264
69. Ciaudo M., Doco-Lecompte T., Guettier C., et al. Revisited indications for bone marrow examinations in HIV-infected patients. Eur J Haematol 53 3 (1994) 168-174
70. Jacobson L.P., Kirby A.J., Polk S., et al. Changes in survival after acquired immunodeficiency syndrome (AIDS): 1984-1991. Am J Epidemiol 138 11 (1993) 952-964
71. Goedert J.J., Cote T.R., Virgo P., et al. Spectrum of AIDS-associated malignant disorders. Lancet 351 9119 (1998) 1833-1839
72. Carr A., and Cooper D.A. Adverse effects of antiretroviral therapy. Lancet 356 9239 (2000) 1423-1430
73. Cribb A.E., Lee B.L., Trepanier L.A., et al. Adverse reactions to sulphonamide and sulphonamide-trimethoprim antimicrobials: clinical syndromes and pathogenesis. Adverse Drug React Toxicol Rev 15 1 (1996) 9-50
74. Jacobson M.A., McGrath M.S., Joseph P., et al. Zidovudine-induced fever. J Acquir Immune Defic Syndr 2 4 (1989) 382-388
75. Fellay J., Boubaker K., Ledergerber B., et al. Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study. Lancet 358 9290 (2001) 1322-1327
76. Shelburne S.A., Visnegarwala F., Darcourt J., et al. Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy. AIDS 19 4 (2005) 399-406
77. Ingiliz P., Appenrodt B., Gruenhage F., et al. Lymphoid pneumonitis as an immune reconstitution inflammatory syndrome in a patient with CD4 cell recovery after HAART initiation. HIV Med 7 6 (2006) 411-414
78. Foulon G., Wislez M., Naccache J.M., et al. Sarcoidosis in HIV-infected patients in the era of highly active antiretroviral therapy. Clin Infect Dis 38 3 (2004) 418-425
79. Davis P., and Stein M. Human immunodeficiency virus-related connective tissue diseases: a Zimbabwean perspective. Rheum Dis Clin North Am 17 1 (1991) 89-97
80. Friedman N.D., and Spelman D.W. Subacute thyroiditis presenting as pyrexia of unknown origin in a patient with human immunodeficiency virus infection. Clin Infect Dis 29 5 (1999) 1352-1353
81. Pacios E., Alcala L., Ruiz-Serrano M.J., et al. Evaluation of bone marrow and blood cultures for the recovery of mycobacteria in the diagnosis of disseminated mycobacterial infections. Clin Microbiol Infect 10 8 (2004) 734-737
82. Deniau M., Canavate C., Faraut-Gambarelli F., et al. The biological diagnosis of leishmaniasis in HIV-infected patients. Ann Trop Med Parasitol 97 Suppl 1 (2003) 115-133
83. O'Doherty M.J., Barrington S.F., Campbell M., et al. PET scanning and the human immunodeficiency virus-positive patient. J Nucl Med 38 10 (1997) 1575-1583
84. Meller J., Sahlmann C.O., and Scheel A.K. 18F-FDG PET and PET/CT in fever of unknown origin. J Nucl Med 48 1 (2007) 35-45
85. Kilby J.M., Marques M.B., Jaye D.L., et al. The yield of bone marrow biopsy and culture compared with blood culture in the evaluation of HIV-infected patients for mycobacterial and fungal infections. Am J Med 104 2 (1998) 123-128
86. Benito N., Nunez A., de Gorgolas M., et al. Bone marrow biopsy in the diagnosis of fever of unknown origin in patients with acquired immunodeficiency syndrome. Arch Intern Med 157 14 (1997) 1577-1580 Fluorodeoxyglucose
87. Engels E., Marks P.W., and Kazanjian P. Usefulness of bone marrow examination in the evaluation of unexplained fevers in patients infected with human immunodeficiency virus. Clin Infect Dis 21 2 (1995) 427-428
88. Ker C.C., Hung C.C., Huang S.Y., et al. Comparison of bone marrow studies with blood culture for etiological diagnosis of disseminated mycobacterial and fungal infection in patients with acquired immunodeficiency syndrome. J Microbiol Immunol Infect 35 2 (2002) 89-93
89. Prego V., Glatt A.E., Roy V., et al. Comparative yield of blood culture for fungi and mycobacteria, liver biopsy, and bone marrow biopsy in the diagnosis of fever of undetermined origin in human immunodeficiency virus-infected patients. Arch Intern Med 150 2 (1990) 333-336
90. Garcia-Ordonez M.A., Colmenero J.D., Jimenez-Onate F., et al. Diagnostic usefulness of percutaneous liver biopsy in HIV-infected patients with fever of unknown origin. J Infect 38 2 (1999) 94-98
91. Cavicchi M., Pialoux G., Carnot F., et al. Value of liver biopsy for the rapid diagnosis of infection in human immunodeficiency virus-infected patients who have unexplained fever and elevated serum levels of alkaline phosphatase or gamma-glutamyl transferase. Clin Infect Dis 20 3 (1995) 606-610
92. Roger P.M., Mondain V., Saint Paul M.C., et al. Liver biopsy is not useful in the diagnosis of mycobacterial infections in patients who are infected with human immunodeficiency virus. Clin Infect Dis 23 6 (1996) 1302-1304
93. Erbel R., Rohmann S., Drexler M., et al. Improved diagnostic value of echocardiography in patients with infective endocarditis by transoesophageal approach: a prospective study. Eur Heart J 9 1 (1988) 43-53
94. Gebo K.A., Burkey M.D., Lucas G.M., et al. Incidence of, risk factors for, clinical presentation, and 1-year outcomes of infective endocarditis in an urban HIV cohort. J Acquir Immune Defic Syndr 43 4 (2006) 426-432
95. Anglaret X., Saba J., Perronne C., et al. Empiric antituberculosis treatment: benefits for earlier diagnosis and treatment of tuberculosis. Tuber Lung Dis 75 5 (1994) 334-340